1-20 of 20
positron-emission tomography
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach

Clinical Trials & Observations
Phoebe T. M. Cheng, Diego Villa, R. Petter Tonseth, David W. Scott, Alina S. Gerrie, Ciara L. Freeman, Tom Pickles, Andrea C. Lo, Pedro Farinha, Jeffrey W. Craig, Graham W. Slack, Randy D. Gascoyne, François Bénard, Don Wilson, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3647–3655.
https://doi.org/10.1182/bloodadvances.2021004375
Published: 2021
Journal Articles

Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma

Clinical Trials & Observations
Marcella Kaddoura, David Dingli, Francis K. Buadi, Martha Q. Lacy, Morie A. Gertz, Angela Dispenzieri, Prashant Kapoor, Lisa Hwa, Amie Fonder, Miriam Hobbs, Suzanne Hayman, John Lust, Nelson Leung, Ronald S. Go, Yi Lin, Wilson Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, Stephen M. Broski, Vincent Rajkumar, Shaji Kumar
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2753–2759.
https://doi.org/10.1182/bloodadvances.2020004131
Published: 2021
Journal Articles

Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma

Karthik Nath, Soi-Cheng Law, Muhammed B. Sabdia, Jay Gunawardana, Lilia M. de Long, David Sester, Mohamed Shanavas, Hennes Tsang, Joshua W. D. Tobin, Sarah-Jane Halliday, Annette Hernandez, Donna Cross, Robert J. Bird, Sanjiv Jain, Colm Keane, Dipti Talaulikar, Judith Trotman, Phillip Law, Maher K. Gandhi
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2644–2649.
https://doi.org/10.1182/bloodadvances.2020004051
Published: 2021
Includes: Supplemental data
Journal Articles

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

Clinical Trials & Observations
J. J. Eertink, C. N. Burggraaff, M. W. Heymans, U. Dührsen, A. Hüttmann, C. Schmitz, S. Müller, P. J. Lugtenburg, S. F. Barrington, N. G. Mikhaeel, R. Carr, S. Czibor, T. Györke, L. Ceriani, E. Zucca, M. Hutchings, L. Kostakoglu, A. Loft, S. Fanti, S. E. Wiegers, S. Pieplenbosch, R. Boellaard, O. S. Hoekstra, J. M. Zijlstra, H. C. W. de Vet
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2375–2384.
https://doi.org/10.1182/bloodadvances.2021004467
Published: 2021
Includes: Supplemental data
Journal Articles

Involved-site radiotherapy for Helicobacter pylori –independent gastric MALT lymphoma: 26 years of experience with 178 patients

Clinical Trials & Observations
Joachim Yahalom, Amy J. Xu, Ariela Noy, Stephanie Lobaugh, Monica Chelius, Karen Chau, Carol Portlock, Carla Hajj, Brandon S. Imber, David J. Straus, Craig H. Moskowitz, Morton Coleman, Andrew D. Zelenetz, Zhigang Zhang, Ahmet Dogan
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1830–1836.
https://doi.org/10.1182/bloodadvances.2020003992
Published: 2021
Journal Articles

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Reid W. Merryman, Robert A. Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, Justin M. Darrah, Uttam Rao, Michael T. Byrne, David A. Bond, Kami J. Maddocks, Michael A. Spinner, Ranjana H. Advani, Hatcher J. Ballard, Jakub Svoboda, Anurag K. Singh, Joseph P. McGuirk, Dipenkumar Modi, Radhakrishnan Ramchandren, Jason Romancik, Jonathon B. Cohen, Matthew J. Frigault, Yi-Bin Chen, Anthony V. Serritella, Justine Kline, Stephen Ansell, Sunita Nathan, Maryam Rahimian, Robin M. Joyce, Mansi Shah, Kevin A. David, Steven Park, Anne W. Beaven, Alma Habib, Veronika Bachanova, Shazia Nakhoda, Nadia Khan, Ryan C. Lynch, Stephen D. Smith, Vincent T. Ho, Ann LaCasce, Philippe Armand, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1648–1659.
https://doi.org/10.1182/bloodadvances.2020003556
Published: 2021
Includes: Supplemental data
Journal Articles

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

Clinical Trials & Observations
Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, David Belada, Angelo-Michele Carella, Neil Chua, Eva Gonzalez-Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Sahin, Gila Sellam, Mikkel Z. Oestergaard, Umberto Vitolo, Marek Trněný
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1283–1290.
https://doi.org/10.1182/bloodadvances.2020002690
Published: 2021
Includes: Supplemental data
Journal Articles

Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice

Lydia A. Perkins, Lea Nyiranshuti, Lynda Little-Ihrig, Joseph D. Latoche, Kathryn E. Day, Qin Zhu, Sina Tavakoli, Prithu Sundd, Enrico M. Novelli, Carolyn J. Anderson
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4102–4112.
https://doi.org/10.1182/bloodadvances.2020002642
Published: 2020
Includes: Supplemental data
Journal Articles

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Erin A. Dean, Rahul S. Mhaskar, Hong Lu, Mina S. Mousa, Gabriel S. Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chavez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3268–3276.
https://doi.org/10.1182/bloodadvances.2020001900
Published: 2020
Includes: Supplemental data
Journal Articles

ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Clinical Trials & Observations
Steven I. Park, Thomas C. Shea, Oludamilola Olajide, Nishitha M. Reddy, Lihua E. Budde, Nilanjan Ghosh, Allison M. Deal, Jeanne F. Noe, Stephen M. Ansell
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2548–2555.
https://doi.org/10.1182/bloodadvances.2020001871
Published: 2020
Includes: Supplemental data
Journal Articles

Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information

Clinical Trials & Observations
Reiko Nakajima, Alison J. Moskowitz, Laure Michaud, Audrey Mauguen, Connie Lee Batlevi, Ahmet Dogan, Heiko Schöder
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1812–1823.
https://doi.org/10.1182/bloodadvances.2020001579
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA

Clinical Trials & Observations
Sarah C. Rutherford, Michael Herold, Wolfgang Hiddemann, Lale Kostakoglu, Robert Marcus, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Judith Trotman, Umberto Vitolo, Tina Nielsen, Federico Mattiello, Deniz Sahin, Gila Sellam, Peter Martin
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1589–1593.
https://doi.org/10.1182/bloodadvances.2019001261
Published: 2020
Includes: Supplemental data
Journal Articles

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

Clinical Trials & Observations
Luca Ceriani, Giuseppe Gritti, Luciano Cascione, Maria Cristina Pirosa, Angela Polino, Teresa Ruberto, Anastasios Stathis, Andrea Bruno, Alden A. Moccia, Luca Giovanella, Stefanie Hayoz, Sämi Schär, Stefan Dirnhofer, Alessandro Rambaldi, Giovanni Martinelli, Christoph Mamot, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1082–1092.
https://doi.org/10.1182/bloodadvances.2019001201
Published: 2020
Journal Articles

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Clinical Trials & Observations
Tim M. Illidge, Elizabeth H. Phillips, Nicholas Counsell, Ruth Pettengell, Peter W. M. Johnson, Dominic J. Culligan, Bilyana Popova, Laura Clifton-Hadley, Andrew McMillan, Peter Hoskin, Sally F. Barrington, John Radford
Journal: Blood Advances
Blood Adv (2020) 4 (1): 203–206.
https://doi.org/10.1182/bloodadvances.2019001023
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua W. D. Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson, Stephen Bell, Chengetai Dunduru, James Gallo, Erica S. Tsang, Xuan Tan, Jonathan Wong, Jessica Pearce, Robert Campbell, Shao Tneh, Sophie Shorten, Melissa Ng, Tara Cochrane, Constantine S. Tam, Emad Abro, Eliza Hawkes, Georgina Hodges, Roopesh Kansara, Dipti Talaulikar, Michael Gilbertson, Anna M. Johnston, Kerry J. Savage, Diego Villa, Kirk Morris, Sumi Ratnasingam, Wojt Janowski, Robert Kridel, Chan Y. Cheah, Michael MacManus, Nicholas Matigian, Peter Mollee, Maher K. Gandhi, Greg Hapgood
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2804–2811.
https://doi.org/10.1182/bloodadvances.2019000458
Published: 2019
Includes: Supplemental data
Journal Articles

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Clinical Trials & Observations
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2013–2021.
https://doi.org/10.1182/bloodadvances.2019000251
Published: 2019
Journal Articles

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma

Clinical Trials & Observations
M. Picardi, R. Della Pepa, C. Giordano, N. Pugliese, C. Mortaruolo, F. Trastulli, M. G. Rascato, I. Cappuccio, M. Raimondo, M. Memoli, M. Monteverde, M. Mascolo, F. Pane
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1546–1552.
https://doi.org/10.1182/bloodadvances.2019000123
Published: 2019
Journal Articles

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma

Clinical Trials & Observations
Neha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, Alison J. Moskowitz, Craig Sauter, Steven M. Horwitz, Heiko Schöder
Journal: Blood Advances
Blood Adv (2019) 3 (2): 187–197.
https://doi.org/10.1182/bloodadvances.2018024075
Published: 2019
Includes: Supplemental data
Journal Articles

Uptake of [ 18 F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma

Clinical Trials & Observations
Shunan Qi, May Y. Huang, Yong Yang, Heiko Schöder, Sewit Teckie, Ariela Noy, Karen Chau, Joachim Yahalom
Journal: Blood Advances
Blood Adv (2018) 2 (6): 649–655.
https://doi.org/10.1182/bloodadvances.2017013698
Published: 2018
Includes: Supplemental data